Pharmacology and Toxicology

EmailEmail    |   Bookmark Page Bookmark  |   RSS Feeds RSS  |   Print Page Print  

Preclinical Testing

The Preclinical Testing will involve assessment of novel drug molecules including genetic, peptide, and antibody-based therapies in cell-based and animal disease models. Expertise in cardiovascular disease, cancer, neuroscience, and infectious diseases will provide advice and assistance with evaluating novel drugs and therapeutic approaches.


Current Project

Evaluating two novel small molecules in kidney and cardiovascular diseases


Evaluating novel small molecules in inflammatory disease


Based on preclinical data in cancer disease models we are providing advice and assistance with going forward with repositioning a drug for clinical trials
© 2015 Medical College of Wisconsin
Page Updated 07/17/2012